Abstract 1554MO
Background
To successfully implement exercise programs for patients with metastatic breast cancer, services and education on expected benefits and how to overcome barriers should be aligned with patient preferences, values, and goals. Hence, gaining insight into patients’ perspectives on exercise and exercise programming is crucial.
Methods
In this cross-sectional survey, we recruited patients from 13 centers in the Netherlands, Germany, Poland, Spain, and Sweden. We collected data on patients’ knowledge about exercise and outcome expectations. We identified barriers to and facilitators for participation in exercise programs, and patients’ preferences for content and modes of exercise delivery.
Results
420 patients completed the survey. Respondents were on average 56 years old and 70% had bone metastases. 65% reported having sufficient skills to engage in aerobic exercise, but only 34% did so for resistance exercise. Overall, respondents expected exercise to have multiple physical benefits, but a few expected exercise to worsen their pain (5%) or fatigue (4%). Feeling too tired (22%) and/or weak (23%) and not having access to an exercise program for cancer patients (26%) were the most prominent barriers. Facilitators for exercising regularly were previous positive physical (70%) and emotional (66%) experiences from exercising, and getting personalized advice from a physiotherapist (60%). Patients were most interested in walking and preferred exercising at a public gym, physiotherapy practice or outdoors, with inter-country differences. 56% did not know whether their insurance company reimburses exercise programs and only 9% would be willing to pay > €50 per month to participate.
Conclusions
A large proportion of patients with metastatic breast cancer reported not having the necessary skills to engage in regular exercise as recommended by current exercise guidelines for people with cancer. Patients may benefit from personalized advice and training facilities where they receive instructions and can practice safe and effective exercises. When implementing exercise interventions for patients with metastatic breast cancer, attention should be given to reimbursement and willingness-to-pay.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital.
Funding
European Union’s Horizon 2020 research and innovation programme.
Disclosure
A.M. May: Financial Interests, Institutional, Advisory Role: COMPASS. K. Steindorf: Financial Interests, Personal, Expert Testimony, < €5,000: Institut National contre le cancer (INCA), Paris, France; Financial Interests, Personal, Expert Testimony, Member of Data Monitoring Board; < €1,000: Swiss Group for Clinical Research (SAAK), Switzerland; Financial Interests, Personal, Invited Speaker, < €1,000: Adviva, Heidelberg, Germany, Pierre Fabre, Freiburg, Germany, Takeda, Breast Cancer Care Center, Unna, Germany, Audi Health Care Insurance, Ingolstadt, Germany, University of Mainz, Germany; Financial Interests, Personal, Invited Speaker, Lecturer fee in Master Course, < €2,000: University of Heidelberg, Germany; Financial Interests, Personal, Expert Testimony, compensation of travel costs, no further fees: German Research Foundation (DFG), Bonn, Germany; Financial Interests, Personal, Expert Testimony, < €1,000: University of Vienna, Vienna, Austria. All other authors have declared no conflicts of interest.
Resources from the same session
1425MO - Use of psychosocial services and 1-year mortality among newly diagnosed and distressed cancer patients: A real-world study
Presenter: Juhee Cho
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1555MO - Effects of exercise on sleep quality and cancer-related fatigue during neurotoxic chemotherapy
Presenter: Jana Müller
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 1425MO, 1554MO and 1555MO
Presenter: Antonio Di Meglio
Session: Mini Oral session: Supportive and palliative care
Resources:
Slides
Webcast
1556MO - The iBLAD study: Patient-reported outcomes in bladder cancer during oncological treatment: A multicenter national randomized controlled trial
Presenter: Gry Assam Taarnhøj
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1557MO - Phase II trial evaluating effect of gonyautoxins (GTX), a paralytic shellfish poisoning (PSP) on objective and subjective symptoms of chemotherapy-induced peripheral neuropathy (CIPN)
Presenter: Mariane Dias
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1558MO - Dissecting sexual health after breast cancer (BC) by longitudinal assessment of patient reported outcomes
Presenter: Maria Alice Franzoi
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 1556MO, 1557MO and 1558MO
Presenter: Maryam Lustberg
Session: Mini Oral session: Supportive and palliative care
Resources:
Slides
Webcast
LBA70 - COVID-19 in cancer patients: Update from the joint analysis of ESMO-CoCARE, BSMO, PSMO international databases
Presenter: Emanuela Romano
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1264MO - Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy
Presenter: Roman Kowalchuk
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1265MO - Cause and place of death in older patients with cancer: Results from a large cohort study using linked clinical and population-based data
Presenter: Victoria Depoorter
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast